openPR Logo
Press release

Europe Drug Delivery Market Will Make Hugh Growth With a CAGR of 7.3% by 2024| Major Players are: Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc.

10-27-2017 02:56 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

"Europe Drug Delivery Market" - Industry Trends and Forecast to 2024

"Europe Drug Delivery Market" - Industry Trends and Forecast to 2024

Europe Drug Delivery Market expected to reach USD 536.1 billion by 2024 from USD 305.5 billion in 2016, at a CAGR of 7.3% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Europe drug delivery market is the second largest revenue pocket for the global drug delivery devices manufacturers with 29.9% market share in 2016.

Request for Sample @ databridgemarketresearch.com/request-a-sample/?dbmr=europ...

Major Market Drivers and Restraints:
• Growing Industry-Academia Collaborations
• Increasing R&D activities and expenditure
• Quality concerns
• Technological developments
• Increasing funding for proteomics research and drug discovery

The Europe drug delivery market is segmented on the basis of product type, technology, components, delivery mode, end-user, and geography.

Browse Full Report @ databridgemarketresearch.com/reports/europe-drug-delivery...

On the basis of route of administration the Europe drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. Based on the route of administration, oral drug delivery market dominates the market in 2016 with 44.5% market share. Injectable drug delivery market is considered to be the fastest growing market with the CAGR of 11.7%.

Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes. The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable.
The Europe pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.

The Europe ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.

The Europe Nasal drug delivery devices are segmented on the basis of product type into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented on the basis of product form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.

On the basis of end users the Europe drug delivery market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. In 2016, the hospitals segment dominates the Europe drug delivery market with more than 60.6% market share.

Based on geography the market is segmented into 11 countries, Germany, France, U.K., Spain, Italy, Russia, Netherlands, Switzerland, Turkey, Belgium, and Rest of Europe. Germany is expected to dominate the market with largest share of 23.6% in 2016. However the drug delivery market in France is expected to be the fastest growing among the other countries in Europe.

Speak to our Analyst: databridgemarketresearch.com/speak-to-analyst/?dbmr=europ...

The Europe Drug Delivery Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in this market are
• Bayer AG
• Johnson & Johnson
• Novartis AG
• Pfizer, Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc.
• Merck & Co.
• Sanofi
• Antares Pharma
• 3M
• Becton Dickinson and Company
• Biolase, Inc.
• Cima Labs, Inc.
• West Pharmaceuticals
• Antares Pharma
• Alkermes
• Foamis
• Ypsomed
• Skyepharma AG
• Valeant Pharmaceuticals
• DSM Biomedical
• Catalent, Inc.

Inquiry before Buying @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Table of Content:
1. INTRODUCTION
1.1. OVERVIEW OF EUROPE DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. GROWTH IN THE DEVELOPMENT OF BIOLOGICS
3.1.3. TECHNOLOGICAL DEVELOPMENT
3.2. RESTRAINTS
3.2.1. RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS
3.3. OPPORTUNITIES
3.3.1. RISING ACCEPTANCE OF SELF ADMINISTERING DRUGS
3.3.2. RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS
3.3.3. TREND OF MERGER AND ACQUISITIONS, AND COLLABORATIONS
3.3.4. FOCUS ON PATIENT NEEDS
3.3.5. DEVELOPING AND NEW EMERGING REVENUE POCKETS
3.4. THREATS
3.4.1. PRODUCT RECALLS
3.4.2. STRINGENT REGULATORY AND HIGH PRICING
3.4.3. PATENT EXPIRY AND PATENT CLIFF
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION
6.1. OVERVIEW
6.2. EUROPE ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.1. EUROPE SOLID ORAL DRUG DELIVERY MARKET,
BY PRODUCT TYPE
6.2.2. EUROPE LIQUID ORAL DRUG DELIVERY MARKET,
BY PRODUCT TYPE
6.2.3. EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET,
BY PRODUCT TYPE
6.3. EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.3.1. EUROPE NEBULIZERS MARKET, BY PRODUCT TYPE
6.4. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.4.1. EUROPE INJECTABLE DRUG DELIVERY DEVICES,
BY PRODUCT TYPE
6.4.2. EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY
DEVICES MARKET
6.4.3. EUROPE SELF-INJECTION DRUG DELIVERY DEVICES MARKET,
BY PRODUCT TYPE
6.4.4. EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE
6.5. EUROPE OPHTHALMIC DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.5.1. EUROPE OCUULAR DRUG DELIVERY FORMULATIONS MARKET,
BY FORM
6.5.2. EUROPE OCCULAR DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.6. EUROPE NASAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.7. EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.7.1. EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET,
BY PRODUCT TYPE
6.7.2. EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET,
BY PRODUCT TYPE
6.7.2.1. EUROPE SEMI SOLID TOPICAL DRUG DELIVERY
FORMULATIONS MARKET, BY TYPE
6.7.2.2. EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS
MARKET, BY TYPE
6.7.2.3. EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS
MARKET, BY TYPE
6.8. EUROPE IMPLANTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9. EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9.1. EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET,
BY PRODUCT TYPE
6.9.2. EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET,
BY PRODUCT TYPE
7. EUROPE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
7.1. OVERVIEW
8. EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER
8.1. OVERVIEW
9. EUROPE DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. EUROPE DRUG DELIVERY MARKET
9.3. GERMANY DRUG DELIVERY MARKET
9.4. U.K. DRUG DELIVERY DEVICES MARKET
9.5. FRANCE DRUG DELIVERY MARKET
9.6. ITALY DRUG DELIVERY DEVICES MARKET
9.7. RUSSIA DRUG DELIVERY DEVICES MARKET
9.8. TURKEY DRUG DELIVERY MARKET
9.9. SWITZERLAND DRUG DELIVERY MARKET
9.10. BELGIUM DRUG DELIVERY DEVICES MARKET
9.11. SPAIN DRUG DELIVERY DEVICES MARKET
9.12. NETHERLANDS DRUG DELIVERY MARKET
10. REST OF EUROPE DRUG DELIVERY MARKET
11. EUROPE DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: EUROPE
12. COMPANY PROFILES
12.1. JOHNSON & JOHNSON
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. PFIZER, INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. 3M
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS

12.4. ANTARES PHARMA, INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. MERCK & CO.
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
13. RELATED REPORTS

Other Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

Report Access: databridgemarketresearch.com/reports/global-drug-delivery...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Drug Delivery Market Will Make Hugh Growth With a CAGR of 7.3% by 2024| Major Players are: Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. here

News-ID: 790727 • Views: 230

More Releases from Data Bridge Market Research

Wireless Sensor Network Market Booming at a CAGR of 20.0% by 2024 Top Key Player …
This Global Wireless Sensor Network Market report analyze top manufacturers of market with sales, revenue and price. It shows global market by regions, with sales, revenue and market share for each region from 2019 to 2026. The Global Wireless Sensor Network Market report analyses sales and distribution channels across key geographies to enhance top-line revenues. Regions covered in this report are North America, Asia and Pacific region. Middle
Global IT in Real Estate Market By Business Outlook, Segmentation and Top Key Pl …
The global IT in real estate market accounted for USD 6.2 billion in 2016 growing at a CAGR of 13.01% during the forecast by 2024. The upcoming market report contains data for historic year 2014, 2015, the base year of calculation is 2016 and the forecast by 2024. Real estate is the property, land, buildings, air rights above the land and underground rights below the land. The term real estate
Dental Sealants Market will Boom By Key Players 3M, Henkel AG & Co. KGaA, Den-Ma …
Global Dental sealants Market is set to witness a stable CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018, and the historic year of 2017. Increasing health expenditure is the major factor for the growth of this market. The Global Dental sealants Market report further sheds light on contenders who have a fundamental influence in fulfilling client's prerequisites. It considers that offering in
Bot Service Market Booming at a CAGR of 32.10% by 2026 Top Key Players Microsoft …
The Global Bot Service Market report finds the markets complete deal that is generated by a specific firm over a timespan. Industry specialists calculates share by considering the product sales over a period and then partitioning it by the general shares of the Semiconductors and Electronics industry over a characterized period. Specialists further utilize this measurement to offer a general thought of the share and size of a firm

All 31317 Releases


More Releases for DRUG

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug and Alcohol Rehab
Although it isn’t something most people talk about or even want to think about, drug and alcohol rehab are places that exist because of an unfortunately high prevalence of a number of different addictions in society. In fact, so many people are having to deal with some sort of drug and alcohol rehab in their personal lives, that a new reality show called “Intervention” is being shown, to educate people